Literature DB >> 11085989

Divergent roles of SHP-2 in ERK activation by leptin receptors.

C Bjørbaek1, R M Buchholz, S M Davis, S H Bates, D D Pierroz, H Gu, B G Neel, M G Myers, J S Flier.   

Abstract

The protein tyrosine phosphatase SHP-2 has been proposed to serve as a regulator of leptin signaling, but its specific roles are not fully examined. To directly investigate the role of SHP-2, we employed dominant negative strategies in transfected cells. We show that a catalytically inactive mutant of SHP-2 blocks leptin-stimulated ERK phosphorylation by the long leptin receptor, ObRb. SHP-2, lacking two C-terminal tyrosine residues, partially inhibits ERK phosphorylation. We find similar effects of the SHP-2 mutants after examining stimulation of an ERK-dependent egr-1 promoter-construct by leptin. We also demonstrate ERK phosphorylation and egr-1 mRNA expression in the hypothalamus by leptin. Analysis of signaling by ObRb lacking intracellular tyrosine residues or by the short leptin receptor, ObRa, enabled us to conclude that two pathways are critical for ERK activation. One pathway does not require the intracellular domain of ObRb, whereas the other pathway requires tyrosine residue 985 of ObRb. The phosphatase activity of SHP-2 is required for both pathways, whereas activation of ERK via Tyr-985 of ObRb also requires tyrosine phosphorylation of SHP-2. SHP-2 is thus a positive regulator of ERK by leptin receptors, and both the adaptor function and the phosphatase activity of SHP-2 are critical for this regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085989     DOI: 10.1074/jbc.M007439200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  118 in total

1.  EGR1 Is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons.

Authors:  Guillaume de Lartigue; Gyorgy Lur; Rod Dimaline; Andrea Varro; Helen Raybould; Graham J Dockray
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 2.  Brain effects of leptin: what intracellular mechanism?

Authors:  Kamal Rahmouni
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 4.810

Review 3.  Obesity, leptin, and Alzheimer's disease.

Authors:  Edward B Lee
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

4.  Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels.

Authors:  Laurence E Ring; Lori M Zeltser
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

Review 5.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 6.  Leptin signalling pathways in hypothalamic neurons.

Authors:  Obin Kwon; Ki Woo Kim; Min-Seon Kim
Journal:  Cell Mol Life Sci       Date:  2016-01-19       Impact factor: 9.261

7.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 8.  Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance.

Authors:  Harvey J Grill; Matthew R Hayes
Journal:  Cell Metab       Date:  2012-08-16       Impact factor: 27.287

9.  Are common leptin promoter polymorphisms associated with restenosis after coronary stenting?

Authors:  Julie Anna Bienertová-Vasků; Ota Hlinomaz; Anna Vasků
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

10.  Changes in Appetite Regulation-Related Signaling Pathways in the Brain of Mice Supplemented with Non-nutritive Sweeteners.

Authors:  Gerson G Contreras-Chavez; José A Estrada; Irazú Contreras
Journal:  J Mol Neurosci       Date:  2020-10-31       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.